Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum.
(2006) Fertility and sterility — Vol. 85, n° 5, p. 1516-1518 (2006)
Files
10532.pdf
Restricted Access - Adobe PDF
- 81.97 KB
Details
- Authors
Lison, Dominique 
- Abstract
- We found, by reverse transcription--real time--polymerase chain reaction, that the expression of aromatase (CYP19) in ovarian, peritoneal endometriosis, and deep endometriotic nodules is significantly different, which strengthens the theory of three distinct clinical entities. Compared with peritoneal endometriosis, ovarian endometriosis exhibits an 8-fold higher expression of aromatase, which suggests that aromatase inhibitors may be particularly active in this form of endometriosis.
- Affiliations
Citations
Heilier, J.-F., Donnez, O., Van Kerckhove, V., Lison, D., & Donnez, J. (2006). Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum. Fertility and sterility, 85(5), 1516-1518. https://doi.org/10.1016/j.fertnstert.2005.10.041 (Original work published 2006)